Article published in Urologia Polska 1997/50/2.

authors

Grzegorz Kata, Mieczysław Koziarski, Tomasz Dzik, Andrzej Borówka, Józef Schier: Katedra i Klinika Urologii AM we Wrocławiu
Kierownik: prof. dr hab. J. Lorenz

keywords

kidney renal cell carcinoma

references

[1] Atzopodien, }., Kirchner, H., Henninen, E. L., Korfer, A., Fenner, M., Marcol,
M., Deckert, M., Francke, A., Jonas, U., Poolwools, H.: European studies ofinter-
leukin-2 in metastatic renal cell carcinoma. Semin. Oncol., 1993, 20, 22-26.
[2] Bono, A. V., Lovisolo, J. A. J.: Renal cell carcinoma-diagnosis and treatment:
state of the art. Eur. Urol., 1997, 31, 47-55.
[3] Brethean, D., Lechayallier, E., Eghazarian, Ch., Grisoni, V., Coulauge, Ch.:
Prognostic significance of incidental renal cell carcinoma. Eur. Urol., 1995, 27,
319-323.
[4] Chewie, R.}., Goldman, D. S., Lindner, A., DeKernion, J. B.: Prognostic implica-
tions ofvena cava extension of renal cell carcinoma. J. Urol., 1982,128, 910-912.
[5] Culine, S., Bkradda, M., Terrier-Lacombe, M. J., Droz, J. R: Treatment of
sarcomatoid renal cell carcinoma. Eur. Urol., 1996, 27,138-141.
[6] Dembowski, J.: Ocena kliniczna nefrektomii radykalnej w leczeniu raka nerki. Wro-
cław, 1985, praca doktorska.
[7] Dembowski, J., Stolarczyk, J.: Ocena czasu przeżycia chorych na raka nerki po
nefrektomii radykalnej. Urol. Pol., 1988, 41,123-127.
[8] Delahunt, B., Bethwaite, P. B., Nacey,}. N.: Occupałional risk for renal cell carcino-
ma. Br. J. Urol., 1997, 75, 578-582.
[9] Fisher, C. G., Wachter, W., Perez, F. R, Miller, J., Weidner, W., Dudeck, J.:
Urologishe Tumoren in Deutschland. Urologe A, 1997, 36,143-150.
[10] Fuji, Y, Ajima, J., Oka, K., Tosaka, A., Takeshara, Y.: Benign renal tumors
detected among healthy adults by abdominal ultrasonography. Eur. Urol., 1995, 27,
124-127.
[11] Gnarra, J. R., Glenn, G. M., Latif, F.: Molecular genetic studies ofsporadic and
familial renal cell carcinoma. Urol. Clin. North. Am., 1993, 20, 207-216.
[12] Giuliani, L., Giberti, C, Martorana, G., Rovida, S.: Radical extensive surgery
for renal cell carcinoma: Long-term results and prognostic factors. J. Urol, 1990,
143, 468-474.
[13] Giuliani, L., Giberti, C, Martorana, G.: Atlas of surgery for renal cancer. Giu-
liani L., Genoa, 1989.
[14] Hobarth, K., Hallas, A., Kramer, G., Aulitzky, W., Gomahr, A., Steiner, G.,
Marberger, M.: Tissue polypeptide specific antigen in renal cell carcinoma. Eur.
Urol., 1996, 30, 89-95.
[15] Homma, Y., Aso, Y.: Effect of a-interferon alone and combined with other antine-
oplastic agents on renal cell carcinoma determined by the tetrazolium microculture
assay. Eur. Urol., 1994, 25,154-170.
[16] Jacąmin, D., Saussine, C, Roca, D., Roy, C, Bollack, C: Multiple tumors in the
same kidney: incidence and therapeutic implications. Eur. Urol, 1992, 21, 32-34.
[17] Kuijpers, D., Kruyt, R. H., Oudkerk, M.: Renal masses: value of ' duplex Dop-
pler ultrasound in the differential diagnosis. J. Urol., 1994,151, 326-328.
[18] Kletscher, B. A., Junqui, Q., Bostwick, D. G., Andrews, P. E., Zincke, H.:
Prospective analysis of multifocality in renal cell carcinoma... J. Urol., 1995,153,
904-906.
[19] Kjaer, M., Engelhom, S. A.: The clinical course and prognosis patients with Soli-
tary metastasis. J. Urol., 1982,120, 540-542.
[20] Lohr, E.: Renal and adrenal tumors. Springer-Verlag, N. York, 1979.
[21] Lee, S. E., Kim, H. H.: Validity of kidney - presenting surgery for localized renal
cell carcinoma. Eur. Urol., 1994, 25, 204-208.
[22] Long, P. J., Choyke, P. L., Shawker, T. A., Robertson, C. A., Pass, H. J.:
\ntraoperative ultrasound in the evaluation of tumor involvment of the inferior vena
cava. J. Urol, 1993,150,13-17.
[23] Meria, P., Toubert, M. E., Cussenot, O., Bassi, S., Jansen, T.: Tumor associa-
ted trypsin inhibitor and renal cell carcinoma. Eur. Urol., 1995, 27, 223-226.
[24] Morgan, W. R., Zincke, H.: Progression and survival after renal consewing sur-
gery for renal cell carcinoma. Experience in 104 patients and extended follow-up. J.
Urol., 1990,144, 852-858.
[25] Newling, D. W. W.: Renal cell carcinoma. Eur. Urol. Update, 1996, 5, 73-78.
[26] Novick, A. C, Streem, S. B., Montie, J. R: Conservative surgery in renal cell
carcinoma. A single Center experience with 100 patients. J. Urol., 1989,141, 835.
[27] Oberneder, R., Kriegmair, M., Staehler, M., Hofsetter, A.: Immunotherapie
des metasłasierten Nierenkarzinoms. Urologe A, 1997, 36,130-137.
[28] Roby, E. L., Shellhammer, P. R: Adrenal gland and renal cell carcinoma: Is ipsi-
lateral adrenalectomy a necessary component of radical nephrectomy?}. Urol., 1986,
135, 453-455.
[29] Robson, Ch., Churchill, B. M., Anderson W.: The results of radical nephrecto-
my for renal cell cancer. J. Urol., 1969,101, 297.
[30] Roth, S., Semjonov, A., Van Ahlen, H., Oberpenning, R, Piechota, H. ]., Her-
tle, L.: Surgical management of renal cell cancer with extension into the vena cava.
Eur. Urol., 1995, 28, 310-313.
[31] Stahler, G., Brkovic, D.: Nierenkarzinome mit V-cava-Befall. Urologe A, 1997,
36,109-116.
[32] Stolarczyk,}., Lorenz, ]., Dembowski, J.: 220 nefrektomii radykalnych z powo-
du raka nerki. Urol. Pol., 1984, 37, 61.
[33] Stolarczyk, J., Lorenz, J., Dembowski, J.: Hiperkalcemia u chorych na raka ner-
ki. Urol. Pol., 1985, 38, 33.
[34] Szymanowski, J., Czubak, M., Herlinger, G.: Własne doświadczenia w chirur-
gii czopów nowotworowych w układzie żylnym u chorych na raka nerki. Urol. Pol.,
1996, 49, 439-442.
[35] Tolion, Th., Stravoravdi, P., Polyzonis, M., Vakalikos, J.: Natural killer cell
aktivation after interferon administration in patients with metastatic renal cell car-
cinoma. Eur. Urol., 1996, 29, 252-256.
[36] Wurth, M. P.: Immunotherapy for metastatic renal cell carcinoma. Urol. Clin.
North. Am., 1993, 20, 283-295.